| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,876 | 6,356 | 6,927 | 9,130 | | Cost of Revenue | 3,561 | 3,154 | 3,191 | 3,891 | | | Gross Profit | 4,315 | 3,202 | 3,736 | 5,239 | | | Operating Expenses | | Research Development | 1,830 | 1,986 | 2,116 | 2,149 | | Selling General and Administrative | 2,923 | 2,877 | 3,056 | 2,957 | | Non Recurring | 181 | 1 | 444 | 229 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (619) | (1,662) | (1,880) | (96) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 79 | 176 | 80 | 173 | | Earnings Before Interest And Taxes | (540) | (1,486) | (1,800) | 77 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (540) | (1,486) | (1,800) | 77 | | Income Tax Expense | (192) | 3,245 | (374) | (103) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (348) | (4,731) | (1,426) | 180 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (348) | (4,731) | (1,426) | 180 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($348) | ($4,731) | ($1,426) | $180 |
|
0.31% Nasdaq 0.00%
Income Statement
